相关实验视频

Updated: Mar 28, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K

用深度学习对阿尔茨海默氏症疾病分类进行多模式融合和纵向分析

Shakhnoza Muksimova1, Sabina Umirzakova1, Jushkin Baltayev2

  • 1Department of Computer Engineering, Gachon University, Sujeong-gu, Seongnam-si 461-701, Gyeonggi-do, Republic of Korea.

Diagnostics (Basel, Switzerland)
|March 28, 2025
PubMed
概括

通过整合多模式成像数据,FusionNet提高了阿尔茨海默病 (AD) 诊断. 这种先进的框架实现了高精度,有助于早期检测和个性化的AD治疗策略.

关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.深度度度学学习 (deep metric learning) 是一种深度度度学.生成性的对抗性网络.轻量级的神经网络是一种轻量级的神经网络.纵向数据分析的数据分析.多模式成像技术多模式成像技术

更多相关视频

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K
Basics of Multivariate Analysis in Neuroimaging Data06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

17.4K

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K